LEGN – legend biotech corporation - american depositary shares (US:NASDAQ)
Stock Stats
News
Legend Biotech Co. (NASDAQ: LEGN) had its price target raised by analysts at Royal Bank of Canada from $85.00 to $86.00. They now have an "outperform" rating on the stock.
Legend Biotech GAAP EPS of -$0.16 beats by $0.02, revenue of $93.99M misses by $47.37M [Seeking Alpha]
Legend Biotech Reports First Quarter 2024 Results and Recent Highlights
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Legend Biotech Co. (NASDAQ: LEGN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $87.00 price target on the stock.
Form 6-K Legend Biotech Corp For: Mar 31
Form 6-K Legend Biotech Corp For: Apr 22
Form 6-K Legend Biotech Corp For: Apr 16
Form 6-K Legend Biotech Corp For: Apr 05
Form SC 13G/A Legend Biotech Corp Filed by: BlackRock Inc.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.